Toxins and Uterine Fibroids

Toxins and Uterine Fibroids

by | Oct 1, 2023

Introduction

Women’s health conditions seem to be dominated by women’s hormones. Estrogen, testosterone, and progesterone are the main players. Thyroid hormones, cortisol, and DHEA have a role as well. These hormones are involved in the development of common conditions affecting women such as fibroids, endometriosis, and PCOS. Environmental toxins that women are exposed to everyday in low doses alter women’s hormones. Toxins can be present in small amounts in our food, water, and cleaning and grooming products. Research has repeatedly proven the link between toxins and women’s hormonal conditions. The main culprits are bisphenols, phthalates, pesticides, and some heavy metals. It is important for patients and practitioners to understand the link between the toxins and women’s hormonal issues, such as fibroids, in order to prevent and treat these conditions.

Fibroids

Uterine leiomyomas, also called fibroids, are an estrogen-driven condition affecting numerous women in the US. They are benign proliferations of smooth muscle cells of the myometrium. They are most common in the reproductive years and regress in menopause as estrogen levels decline. Fibroids account for a majority of hysterectomies done in the US. But not all fibroids cause symptoms or require surgery. Generally, they become a problem when their location results in heavy bleeding or spotting affecting a woman’s quality of life. They can be located in the muscular wall of the uterus, called intramural, just beneath the uterine serosa, called subserosa, and beneath the endometrium, called submucosal. Some can be pedunculated, meaning it remains connected to the uterus with a stalk.1,2

Fibroids are hormonally responsive to both estrogen and progesterone. Risk factors include race (more prevalent in African American women), early menarche, nulliparity, perimenopause, alcohol use, oral contraceptive use, and hormone replacement therapy—the theme being hormones. Estrogen can induce their growth as seen during pregnancy. It is believed estrogen may stimulate the production of progesterone receptors in the myometrium; and, then, progesterone stimulates the production of growth factors causing the growth of fibroids.1,2

The exact mechanism is unclear. The influence of endocrine-disrupting chemicals (EDCs) is, however, becoming clear.

Bisphenol-A (BPA)

BPA is a known endocrine-disrupting chemical present in the lining of canned food, soda and beer cans, reusable plastic beverage bottles (Polycarbonate plastic #7), dental sealants, and paper receipts from a cash register. Women are exposed daily without knowing its impact on hormonal health. A recent study measuring urinary concentrations of BPA in almost 500 women with fibroids compared to women without fibroids showed a clear connection.3 Urinary BPA levels were higher in women with fibroids compared to those without fibroids. Studies trying to determine the mechanism of action of BPA on fibroid growth and development have shown that BPA promotes the growth of fibroid cells and the expressions of estrogen receptor alpha (ERa), insulin-like growth factor-1 (IGF-1), and vascular endothelial growth factor (VEGF).4 Some studies on the link between BPA and fibroids show inconsistent results. A 2013 study looking at blood BPA levels and fibroids showed there were no differences in the blood BPA level among women with and without fibroids. However, some statistical differences were present among subgroups classified by the size of the uterine fibroid; the more severe the uterine fibroid was, the higher the level of BPA.5

Phthalates

Phthalates are known endocrine-disrupting compounds present in many consumer products. They are used in vinyl flooring, plastic clothes and household items (raincoats, shower curtains and placemats), soaps, shampoos, hair sprays, nail polishes, garden hoses, inflatable toys, medical tubing, and some children’s toys. They are in anything fragranced such as some perfumes, deodorants, laundry detergents, and more. Phthalates are in food items such as meats and cheeses, plastic food storage containers, and wraps. They are hard to avoid and harder to identify on a label because there are many forms, including DBP (dibutyl phthalate), DINP (diisononyl phthalate), DEP (diethyl phthalate), DEHP (di 2-ethylhexl phthalate), DMP (dimethyl phthalate), BBP (benzyl butyl phthalate), DNOP (di-noctyl phthalate), and DIDP (diisodecyl phthalate). Phthalates are linked to many hormonal conditions, including uterine fibroids.

A small study done in 2016 looked at the urinary concentration of 16 phthalate metabolites in 57 women with and without uterine fibroids. DEHP was significantly associated with fibroids.6 A second small study in 2016 again showed phthalates linked to fibroids. Urinary levels of the phthalate monoesters MiBP, MnBP, MEHP, MEHHP, MECPP, DEHP, and DBP were elevated in women with fibroids compared to controls.7 These were small, case-controlled studies, and critics want larger studies to prove a correlation. A 2010, cross-sectional study was done of four urinary phthalate metabolites in relation to uterine fibroids among 1,227 women, age 20-54, from three cycles of the National Health and Nutrition Examination Survey (NHANES), 1999-2004. This was a large population-based study that showed an association between the DBP phthalate metabolite MBP and uterine fibroids.8

Persistent Organic Pollutants (POPs)

Persistent organic pollutants include chemicals used as industrial solvents or lubricants and their byproducts such as polychlorinated biphenyls (PCBs), polybrominated biphenyls (PBBs), and dioxins. POPs also include pesticides such as methoxychlor, chlorpyrifos, and dichlorodiphenyltrichloroethane (DDT). Many POPs are known endocrine-disrupting compounds altering hormone function or synthesis and may bind to estrogen receptors affecting hormonally mediated conditions. A 2015 study looked at the link between persistent organic pollutants and fibroids. Adipose and serum samples from 473 women with fibroids showed an association between serum dichlorodiphenyldichloroethylene (DDE), a metabolite of DDT, and adipose polychlorinated biphenyls (PCBs).9 This confirms results of previously published studies linking POPs and fibroids.9 DDT is a pesticide banned in the US in the early 1970s but persists in rivers, lakes, and soil. PCBs were used in manufacturing and other industries in the US until the late 1970s when they were banned. PCBs were released into the air, water, and land through sewers, smokestacks, storm water runoff, spills, and direct application to the environment. They continue to persist in rivers, lakes, and soil. Today, women are exposed to DDT and PCBs mostly through their diet.

Cadmium

The heavy metal cadmium has been implicated in the development and progression of fibroids. Women are exposed to cadmium mostly through cigarette smoking, drinking water, and diet. Dietary sources of cadmium include seafood (particularly shellfish), rice, and non-organic leafy green and root vegetables. Cadmium is a known endocrine-disrupting metal. It can bind to estrogen receptor alpha, increasing expression, and nongenomic signaling pathways such as mitogen-activated protein kinase (MAPK). Also, cadmium has known estrogenic effects on female reproductive organs.10 Studies linking fibroids and cadmium provide inconsistent results and the method of heavy metal testing appears to account for some of the differences. For example, a 2014 study of 473 women with fibroids compared to women without fibroids found an association between whole blood cadmium but not urinary levels of cadmium.11 It is significant that the link was made with blood cadmium and not urine because urinary cadmium is thought of as the best way to measure cadmium in the body.

Cadmium has a direct effect on fibroids. It has been shown to induce growth in estrogen-responsive human uterine fibroid and myometrial cells. A recent study showed low levels of cadmium could induce cell proliferation in estrogen-responsive uterine fibroid cells.12 It also found the mechanism of action was through activation of the MAPK pathway rather than through direct interactions with estrogen receptor α and estrogen receptor β. As more studies are being done linking EDCs to uterine fibroids, the mechanism of action is becoming clear.

Summary

Endocrine-disrupting compounds are common in our environment. They are present in our air, water, food, plastics, cleaning products, cosmetic and grooming products, and other household items. Common EDCs include bisphenol-A, phthalates, persistent organic pollutants, and heavy metals such as cadmium. These toxins exert a hormone-disrupting effect, contributing to or exacerbating women’s health conditions. Uterine fibroids are a common estrogen-driven condition that is linked to many of these compounds. It is important for both patients and practitioners to know the sources of exposure to these toxins in order to avoid them and prevent the development of fibroids and other hormonal health conditions.

This article was first published in Townsend Letter, April 2017.

References

1. Beckmann CRB, et al. Obstetrics and Gynecology. 7th edition. Baltimore MD: Lippincott Williams and Wilklns; 2014.

2. Callahan TL, Caughey AB. Blueprints Obstetrics and Gynecology. 6th edition. Baltimore MD: Lippincott Williams and Wilkins; 2013.

3. Pollack AZ, et al. Bisphenol A, benzophenone-type ultraviolet filters, and phthalates in relation to uterine leiomyoma. Environ Res. 2015; 137:101-7.

4. Shen Y, et al. An evidence in vitro for the influence of bisphenol A on uterine leiomyoma. Eur J Obstet Gynecol Reprod Biol. 2014; 178:80-3.

5. Jeong EH, et al. The Relationship between Uterine Myoma Growth and the Endocrine Disruptor in Postmenopausal Women. J Menopausal Med. 2013; 19(3):130-4.

6. Kim YA, et al. Increased Urinary Phthalate Levels in Women with Uterine Leiomyoma: A CaseControl Study. See comment in PubMed Commons below/nt J Environ Res Public Health. 2016; 13(12):1247.

7. Sun J, et ai. Phthalate monoesters in association with uterine leiomyomata in Shanghai. Int J Environ Health Res. 2016; 26(3):306-16.

8. Weuve J, et al. Association of exposure to phthalates with endometriosis and uterine leiomyomata: findings from NHANES, 1999-2004. Environ Health Perspect. 2010; 118(6):825-32.

9. Trabert B, et al. Persistent organic pollutants (POPs) and fibroids: results from the ENDO study. J Expo Sei Environ Epidemiol. 2015; 25(3):278-85.

10. Pollack AK, et al. Cadmium and Reproductive Health in Women: A Systematic Review of the Epidemiologic Evidence. Curr Environ Health Rep. 2014; 1(2):172-184.

11. Johnstone EB, et al. Increased urinary cobalt and whole blood concentrations of cadmium and lead in women with uterine leiomyomata: Findings from the ENDO Study. Reprod Toxicol. 2014; 49:2732.

12. Gao X, et al. Cadmium and proliferation in human uterine leiomyoma cells: evidence of a role for EGFR/MAPK pathways but not classical estrogen receptor pathways. Environ Health Perspect. 2015; 123{4):331-6.

Author

  • Marianne Marchese, ND

    Marianne Marchese, ND, is the author of 8 Weeks to Women's Wellness. She graduated from the National University of Natural Medicine in 2002. Dr. Marchese maintains private practice in Phoenix, Arizona, and currently teaches gynecology and environmental medicine at Sonoran University of Health Sciences in Tempe, AZ. She has also been adjunct faculty at Southwest College of Naturopathic Medicine and Bastyr University. Dr. Marchese was named in Phoenix Magazine's Top Doctor Issue as one of the top naturopathic physicians in Phoenix several years running. She lectures on topics related to women's health and environmental medicine throughout the US and Canada.

    View all posts

Already Subscribed?

Search

Formatting updates are ongoing for older articles.

Author

Featured Articles

Where are your Clinical Trials?

It has proven to be difficult, if not impossible, to proceed to full-scale randomized controlled trials (RCTs) for most of the natural methods that cannot be patented or otherwise monopolized. 

A Renewed Focus on Self-Help for Healing

As the producer of The Moss Report, the year leading up to the Covid-19 pandemic was filled with anticipation and excitement. We had invested years of hard work and significant resources into two major projects: our feature film, Immunotherapy: The Battle Within, and...

Issue Archives

Event Calendar

  • 2026 Association of Natural Health Conference

    Douglasville Conference Center Douglasville, GA, United States

    "From Practitioner to Leader: Clinical Excellence, Business Mastery & Sustainable Practice" Discover how clinical excellence, business mastery, and sustainable systems can help practitioners grow into confident leaders and build practices designed for long-term impact. Why Attend? Three days of learning, connection, and growth designed for every stage of your practice journey. Learn from Leading Voices Gain insights from top experts in natural health, holistic wellness, and functional medicine. Hands-On Learning Participate in in-depth workshops, real-world case studies, and interactive sessions you can apply immediately. Meaningful Networking Connect with like-minded professionals, students, and exhibitors who share your passion for natural health. Practical Tools & Approaches Explore new strategies and tools to elevate both your practice and your own health journey. Who Should Attend? This conference is built for a wide community of natural health professionals, educators, and advocates - wherever you are in your journey. Licensed & Clinical Practitioners Doctors, chiropractors, acupuncturists, naturopaths, and functional or integrative medicine practitioners looking to sharpen clinical skills and grow into stronger practice leaders. Allied Health Professionals Bio-feedback technicians and other allied practitioners seeking hands-on training and the latest tools in natural and holistic care. Educators & Students Natural health educators and students entering the […]

  • Food as Medicine Global 2026

    Virtual Event

    Join health professionals, farmers, food producers, researchers, educators, nonprofit leaders, chefs, policymakers, community organizers, food advocates, public health practitioners, nutritionists, and other changemakers as we convene to share knowledge, build partnerships, and explore new possibilities for improving health, strengthening communities, and creating more equitable and sustainable food systems. This year’s program features inspiring speakers and practical examples of collaboration at the intersection of food, health, social justice, and planetary well-being. Together, we’ll explore innovative approaches to Food as Medicine, community-led initiatives, nutrition, public health, regenerative agriculture, and equitable access to healthy food. Whether you work in health care, agriculture, food production, education, research, policy, or community development, you will discover new ideas, meaningful connections, and practical strategies to advance healthier, more resilient communities. Virtual  |  Join from anywhere in the world Check out the Program: https://tinyurl.com/Food-as-Medicine-for-All

  • The Midlife Women’s Health Summit: Evidence-Based Menopause Care in the Era of Longevity Medicine

    The Ritz-Carlton, Pentagon City 1250 S Hayes St, Arlington, VA, United States
    Hybrid Event

    Menopause Care in the Longevity Era Longevity medicine is everywhere right now. Supplements, protocols, influencer clinics, patients walking in with questions about interventions their doctors have never heard of. What's missing from most of it is the evidence. The Midlife Women's Health Summit is three days on what the research actually says about menopause care when you add a longevity lens. What works, what doesn't, what's being oversold, and what to tell the patient sitting in front of you. Co-chaired by Lisa Larkin, MD, FACP, MSCP, IF, Jen Gunter, MD, FRCS(C), FACOG, DABPM, ABPMR, and Lauren Streicher, MD, FACOG, MSCP; three of the clearest voices in women's health on separating data from marketing.

    $995 – $1299

Related Posts

Exposure, Activity, Contribution: Reading Epstein-Barr Findings in the Individual Patient

Robert Lamberton, BSc, FNTP – Epstein-Barr virus accounts for roughly 2% of cancers worldwide, approaching 360,000 new cases and as many as 210,000 deaths each year, and about 95% of adults carry it. In the overwhelming majority, it causes nothing at all.

When a test for an agent is positive in nearly everyone, a positive test is not a finding. It is a background condition.

Read More

Before Gerson: The Forgotten Medical History of Coffee Enemas

By Scott Wilson – In 1875, Dr. J.P. Thomas wrote about using coffee enemas for opium and belladonna poisoning. He referred to cases going back to 1858 and 1859 and described coffee enemas as one of the ordinary means of treatment. That word “ordinary” stopped me. He wasn’t describing an experiment. He was describing something physicians already knew.

Read More

0 Comments

Submit a Comment